Novel tyloindicines and related processes, pharmaceutical compositions and methods

Details for Australian Patent Application No. 2003217373 (hide)

Owner Yale University University of Tennessee Research Foundation

Inventors Baker, David, C.; Cheng, Yung-Chi; Zhong, Sanbao

Agent A.P.T. Patent and Trade Mark Attorneys

Pub. Number AU-B-2003217373

PCT Number PCT/US03/04072

PCT Pub. Number WO2003/070166

Priority 60/357,354 15.02.02 US

Filing date 12 February 2003

Wipo publication date 9 September 2003

Acceptance publication date 30 April 2009

International Classifications

A61K 31/437 (2006.01)

A61P 1/04 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/14 (2006.01) Drugs for disorders of the cardiovascular system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 11/16 (2006.01) Drugs for disorders of the respiratory system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 17/02 (2006.01) Drugs for dermatological disorders

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 19/02 (2006.01) Drugs for skeletal disorders

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/20 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

A61P 37/06 (2006.01) Drugs for immunological or allergic disorders

A61P 37/08 (2006.01) Drugs for immunological or allergic disorders

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/357,354 15.02.02 US

9 October 2003 Application Open to Public Inspection

  Published as AU-B-2003217373

12 August 2004 Change of Name(s) of Applicant(s), Section 104

  Yale University; University of Tennessee Research Corporation The name of the applicant has been changed to Yale University; University of Tennessee Research Foundation

30 April 2009 Application Accepted

  Published as AU-B-2003217373

27 August 2009 Standard Patent Sealed

8 September 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003217374-SINGLE-ENDED CURRENT SENSE AMPLIFIER

2003217372-DISPERSIONS CONTAINING BICOMPONENT FLUOROPOLYMER PARTICLES AND USE THEREOF